with a wide scale of severity along the way. "Once you have atopic dermatitis, you will have it for life, though symptoms may ...

Kymera Therapeutics announced new clinical trials for KT-621, targeting atopic dermatitis ... as Eczema Area and Severity Index (EASI) and pruritus numerical rating scale (NRS).

Study: Facets of shame and their impact on quality of life in patients with atopic dermatitis and psoriasis ... patients were negligible, disease severity was found to be strongly correlated ...

Kymera reports a narrower-than-expected loss for the first quarter of 2025. The company expects the current cash balance to provide a runway into the first half of 2028.

At week 24, the groups assigned to the IL-4 drug had significantly greater mean reductions in Itch Severity Score over ... occur with CSU -- such as atopic dermatitis and asthma -- providing ...

2 Trap Falls Road Suite 106, Shelton, CT 06484 USA Ph: +1-203-852-6800, 800-243-6002 ...

SAD/MAD Phase 1 healthy volunteer trial with data to be reported in June 2025 First patient dosed in KT-621 (STAT6) BroADen Phase 1b trial in moderate to severe atopic dermatitis ...

With this FDA decision, Dupixent is now approved for seven chronic, debilitating atopic conditions driven in part by ... in itch at 24 weeks (measured by the weekly itch severity score, 0-21 scale).

Data from icotrokinra ICONIC-TOTAL show 66% of patients with scalp psoriasis and 77% with genital psoriasis achieved site-specific clear or almost clear skin at Week 16Icotrokinra continues to ...